CN103750106B - 适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 - Google Patents
适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 Download PDFInfo
- Publication number
- CN103750106B CN103750106B CN201410031586.8A CN201410031586A CN103750106B CN 103750106 B CN103750106 B CN 103750106B CN 201410031586 A CN201410031586 A CN 201410031586A CN 103750106 B CN103750106 B CN 103750106B
- Authority
- CN
- China
- Prior art keywords
- yak
- polypeptide
- powder
- abortion
- post
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 46
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 41
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 40
- 239000000843 powder Substances 0.000 title claims abstract description 40
- 206010000210 abortion Diseases 0.000 title claims abstract description 20
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 235000020255 yak milk Nutrition 0.000 claims abstract description 24
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- 239000005862 Whey Substances 0.000 claims abstract description 12
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 12
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 244000308495 Potentilla anserina Species 0.000 claims abstract description 11
- 235000016594 Potentilla anserina Nutrition 0.000 claims abstract description 11
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 11
- 229930003231 vitamin Natural products 0.000 claims abstract description 11
- 235000013343 vitamin Nutrition 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- 229940088594 vitamin Drugs 0.000 claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- 239000005018 casein Substances 0.000 claims abstract description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021240 caseins Nutrition 0.000 claims abstract description 9
- 238000011084 recovery Methods 0.000 claims abstract description 9
- 102000040350 B family Human genes 0.000 claims abstract description 8
- 108091072128 B family Proteins 0.000 claims abstract description 8
- 210000003022 colostrum Anatomy 0.000 claims abstract description 8
- 235000021277 colostrum Nutrition 0.000 claims abstract description 8
- 102000008186 Collagen Human genes 0.000 claims abstract description 7
- 108010035532 Collagen Proteins 0.000 claims abstract description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 7
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 7
- 229920001436 collagen Polymers 0.000 claims abstract description 7
- 229940035035 polydextrose Drugs 0.000 claims abstract description 7
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 7
- 239000001259 polydextrose Substances 0.000 claims abstract description 7
- 239000011734 sodium Substances 0.000 claims abstract description 7
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 6
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 6
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 6
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 229960003080 taurine Drugs 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 claims abstract description 4
- 101710176384 Peptide 1 Proteins 0.000 claims abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 6
- 206010000234 Abortion spontaneous Diseases 0.000 abstract description 5
- 208000000995 spontaneous abortion Diseases 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 5
- 208000015994 miscarriage Diseases 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- VVVDGSCGBGBGFN-UHFFFAOYSA-O 2-[decoxy(hydroxy)phosphoryl]oxyethyl-trimethylazanium Chemical compound CCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C VVVDGSCGBGBGFN-UHFFFAOYSA-O 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000031271 Unwanted pregnancy Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 102000023856 peptide binding proteins Human genes 0.000 description 1
- 108091008399 peptide binding proteins Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法,主要成分为牦牛乳蛋白多肽粉20%~28%,胶原蛋白肽1%~2%,酪蛋白酸钠8%~10%,乳清蛋白粉15%~25%,脱脂奶粉8%~10%,牛初乳1%~2%,牛磺酸0.11%~0.13%,乳酸亚铁0.08%~0.1%,蕨麻提取物1.1%~1.5%,山药提取物1.2%~1.6%,维生素C 0.1%~0.3%,维生素E0.01%~0.02%,B族维生素0.004%~0.008%,聚葡萄糖12%~14%,低聚果糖6%~10%,麦芽糊精10~14%。通过以上功能性营养素的协同作用,全面补充流产后女性所需营养物质,预防流产后常见的妇科炎症,帮助身体恢复。
Description
技术领域
本发明属于乳制品领域,涉及适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法。
背景技术
近年,由于生活压力不断增大,婚检率的大幅度下降,晚婚晚育的人增多,意外怀孕的几率上升以及环境污染日渐严重,有毒有害物质的广泛接触等原因,自然流产、人工流产、药物流产等的发生率逐年增加。虽然流产不如分娩那样对身体影响大,但毕竟对身体也有影响,流产也会失血,再加上怀孕早期阶段的妊娠反应,所以流产后的女性一般身体都会变得比较虚弱,机体抵抗力下降,可能发生很多感染,有人还会出现贫血。
因此,流产后应重视饮食的补养,这对女性身体健康是完全必要的。首先补充蛋白质,流产后由于身体较虚弱,而蛋白质是抗体的重要组成成分,如摄入不足,则机体抵抗力降低。其次,补充矿物质元素铁,由于出血,矿物质流失,而铁元素是机体造血所必需物质,因此摄入不足容易使女性气血不足,引发贫血。再次,补充一定维生素,流产后女性易出现心理压力,造成身体恢复慢,而维生素的补充,一定程度上能够缓解心理压力,促进身体恢复。
发明内容
本发明的目的是提供一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉;
本发明的另一个目的是提供一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉的制备方法。
本发明技术方案如下:一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉,是由下述重量百分比的原料制成:牦牛乳蛋白多肽粉20%~28%、胶原蛋白肽1%~2%、酪蛋白酸钠8%~10%、乳清蛋白粉15%~25%、脱脂奶粉8%~10%、牛初乳1%~2%、牛磺酸0.11%~0.13%、乳酸亚铁0.08%~0.1%、蕨麻提取物1.1%~1.5%、山药提取物1.2%~1.65%、维生素C0.1%~0.3%、维生素E0.01%~0.02%、B族维生素0.004%~0.008%、聚葡萄糖12%~14%、低聚果糖6%~10%和麦芽糊精10%~14%。
优选的,所述B族维生素包含维生素B1、维生素B2、维生素B6和维生素B12。
一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉的生产方法,包括以下步骤:
A、包埋:将酶水解的牦牛乳蛋白多肽粉溶解,添加与牦牛乳蛋白多肽粉等量的β-环状糊精,充分混匀后进行包埋;
B、喷雾干燥:在包埋的多肽粉里面添加蕨麻提取物和山药提取物,进行喷雾干燥;
C、预处理过筛:将牦牛乳蛋白多肽粉、乳清蛋白粉、脱脂奶粉分别过筛,保持各原料细度抑制,使原料混合更加均匀;
D、混合:按等量递增法加入其他物料,进入混合机内进行充分混匀;
E、灭菌、包装:待充分混匀后杀菌,再进行包装,即可得到成品。
优选的,所述步骤A中酶水解的牦牛乳蛋白多肽粉的料水比为1:10。
优选的,所述步骤B中喷雾干燥的进风温度为165℃,排风温度为85℃。
优选的,所述步骤C中将牦牛乳蛋白多肽粉、乳清蛋白粉、脱脂奶粉分别过100目筛。
本发明所用蕨麻提取物、山药提取物购于陕西慧科植物开发有限公司,原料安全,无任何其它成分添加。
本发明产品配伍关系为:以牦牛乳蛋白多肽、酪蛋白酸钠、乳清蛋白粉为主要蛋白质来源,添加的牦牛乳蛋白多肽富含多种肽类物质(如酪蛋白磷酸肽、酪蛋白糖巨肽、免疫活性肽、抗氧化肽、抗菌肽),具有提高矿物质的吸收、提高免疫力、防止细菌侵害、抗氧化减肥的作用。配以牛初乳、胶原蛋白肽辅助提高机体免疫力,牛初乳中含有7种以上的生长因子、免疫球蛋白、生物活性肽结合蛋白及人体所需的维生素和微量元素可提高系统免疫力、调节肠道菌群,并促进胃肠道生长发育或肠道组织创伤的愈合、延缓衰老、促进生长发育等。同时添加膳食纤维聚果糖和聚葡萄糖辅助牦牛乳酪蛋白多肽来帮助预防便秘;将山药提取物、百合提取物、牦牛乳酪蛋白多肽和铁元素根据配伍关系复配,可提高铁元素吸收,不仅能够补血益气,帮助身体恢复,而且可以有效预防贫血,防止流产后感染妇科炎症。添加的山药提取物具有助五脏,补中益气,益胃补肾等功效,对妇女带下白浊,肥胖等有良好作用。添加的蕨麻提取物具有健脾益胃,收敛止血,补血益气的功效,对病后贫血,营养不良等有良好的作用。
通过以上功能性营养素的协同作用,全面补充流产后女性所需营养物质,预防流产后常见的妇科炎症,帮助身体恢复。
具体实施方式
实施例1
配方(克/100克营养粉):
牦牛乳蛋白多肽粉20%,胶原蛋白肽2%,酪蛋白酸钠10%,乳清蛋白粉15%,脱脂奶粉10%,牛初乳2%,牛磺酸0.11%,乳酸亚铁0.1%,蕨麻提取物1.5%,山药提取物1.2%,维生素C 0.1%,维生素E0.01%,B族维生素0.004%,聚葡萄糖14%,低聚果糖10%,麦芽糊精13.976%。
生产方法如下:
A、包埋:将酶水解的牦牛乳蛋白多肽粉溶解,酶水解的牦牛乳蛋白多肽粉的料水比为1:10,添加与牦牛乳蛋白多肽粉等量的β-环状糊精,充分混匀后进行包埋;
B、喷雾干燥:在包埋的多肽粉里面添加蕨麻提取物和山药提取物,进行喷雾干燥,喷雾干燥的进风温度为165℃,排风温度为85℃;
C、预处理过筛:将牦牛乳蛋白多肽粉、乳清蛋白粉、脱脂奶粉分别过100目筛,保持各原料细度抑制,使原料混合更加均匀。
D、混合:按等量递增法加入其他物料,进入混合机内进行充分混匀;
E、灭菌、包装:待充分混匀后在85℃条件下杀菌15s后进行包装,即可得到成品。
实施例2
配方(克/100克营养粉):
牦牛乳蛋白多肽粉23%,胶原蛋白肽1.5%,酪蛋白酸钠8%,乳清蛋白粉19%,脱脂奶粉9%,牛初乳1.5%,牛磺酸0.12%,乳酸亚铁0.09%,蕨麻提取物1.3%,山药提取物1.65%,维生素C 0.2%,维生素E0.015%,B族维生素0.006%,聚葡萄糖12.619%,低聚果糖8%,麦芽糊精14%。生产方法:同实施例1。
实施例3
配方(克/100克营养粉):
牦牛乳蛋白多肽粉260126%,胶原蛋白肽1%,酪蛋白酸钠8%,乳清蛋白粉25%,脱脂奶粉8%,牛初乳1%,牛磺酸0.13%,乳酸亚铁0.08%,蕨麻提取物1.1%,山药提取物1.2%,维生素C 0.3%,维生素E0.02%,B族维生素0.008%,聚葡萄糖12%,低聚果糖6%,麦芽糊精10%。生产方法:同实施例1。
对实施例产品的抗氧化、抗衰老作用进行检验验证,其实验如下:
动物采用雌性小鼠(体重为18~22g),随机分成4组,实验按人推荐量(20g/60kg/d)的5倍、10倍、20倍(1.66、3.33、6.66g/kg/bw)三个剂量组和蒸馏水对照组,3个受试组给予不同剂量受试蛋白粉,30天后,处死各组小鼠,取出肝脏组织,浸入生理盐水20min挤出血液,洗净用滤纸吸干水分,称重,进行测定,得到结果见表一,表一结果看出:小鼠体内MDA的含量随受试剂量的增加而明显降低,SOD与GSH含量均有所增加,由此判断蛋白多肽营养粉对小鼠肝组织脂质过氧化产物MDA的生成有显著抑制作用,该产品具有抗脂质过氧化的作用。
Claims (4)
1.一种适用于流产后女性身体复原的牦牛蛋白多肽营养粉,其特征在于它是由下述重量百分比的原料制成:牦牛乳蛋白多肽粉20%~28%、胶原蛋白肽1%~2%、酪蛋白酸钠8%~10%、乳清蛋白粉15%~25%、脱脂奶粉8%~10%、牛初乳1%~2%、牛磺酸0.11%~0.13%、乳酸亚铁0.08%~0.1%、蕨麻提取物1.1%~1.5%、山药提取物1.2%~1.65%、维生素C0.1%~0.3%、维生素E0.01%~0.02%、B族维生素0.004%~0.008%、聚葡萄糖12%~14%、低聚果糖6%~10%和麦芽糊精10%~14%。
2.权利要求1所述的适用于流产后女性身体复原的牦牛蛋白多肽营养粉,其特征在于:所述B族维生素包含维生素B1、维生素B2、维生素B6和维生素B12。
3.权利要求1所述的适用于流产后女性身体复原的牦牛蛋白多肽营养粉的生产方法,其特征在于它包括以下步骤:
A、包埋:将酶水解的牦牛乳蛋白多肽粉溶解,添加与牦牛乳蛋白多肽粉等量的β-环状糊精,充分混匀后进行包埋;
B、喷雾干燥:在包埋的多肽粉里面添加蕨麻提取物和山药提取物,进行喷雾干燥;
C、预处理过筛:将牦牛乳蛋白多肽粉、乳清蛋白粉、脱脂奶粉分别过筛;
D、混合:按等量递增法加入其他物料,进入混合机内进行充分混匀;
E、灭菌、包装:待充分混匀后杀菌,再进行包装,即可得到成品;
所述步骤A中酶水解的牦牛乳蛋白多肽粉的料水比为1:10,所述步骤B中喷雾干燥的进风温度为165℃,排风温度为85℃。
4.权利要求3所述的适用于流产后女性身体复原的牦牛蛋白多肽营养粉的生产方法,其特征在于:所述步骤C中将牦牛乳蛋白多肽粉、乳清蛋白粉、脱脂奶粉分别过100目筛。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410031586.8A CN103750106B (zh) | 2014-01-23 | 2014-01-23 | 适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410031586.8A CN103750106B (zh) | 2014-01-23 | 2014-01-23 | 适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103750106A CN103750106A (zh) | 2014-04-30 |
CN103750106B true CN103750106B (zh) | 2015-08-26 |
Family
ID=50517560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410031586.8A Active CN103750106B (zh) | 2014-01-23 | 2014-01-23 | 适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103750106B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106036916A (zh) * | 2016-06-02 | 2016-10-26 | 王斐芬 | 术后修复营养品 |
CN106962941B (zh) * | 2017-03-22 | 2021-01-26 | 深圳太太药业有限公司 | 一种用于产后、哺乳调养的海洋膳食组合物及其制备方法 |
CN109691606A (zh) * | 2017-11-24 | 2019-04-30 | 上海冬泽特医食品有限公司 | 一种用于产妇生产时服用的饮料 |
CN108142925A (zh) * | 2017-12-04 | 2018-06-12 | 千人计划创新药物与食品安全研究院扬州有限公司 | 一种医学用途整蛋白全营养配方食品及其制备方法 |
CN112021578A (zh) * | 2020-09-09 | 2020-12-04 | 甘肃华羚生物技术研究中心有限公司 | 一种抗氧化牦牛乳蛋白肽粉及其制备方法 |
CN112741155A (zh) * | 2021-01-19 | 2021-05-04 | 海普诺凯营养品有限公司 | 一种养颜营养粉及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102077945B (zh) * | 2010-09-20 | 2013-05-01 | 王强 | 一种人流、产后专用的海洋特膳食品 |
CN102246967B (zh) * | 2011-05-25 | 2013-01-16 | 广州邦世迪生物技术有限公司 | 常规型全营素 |
CN102308940B (zh) * | 2011-08-08 | 2012-08-08 | 山东鲁健生物医药科技有限公司 | 一种供术后人群食用含低聚肽和低聚糖的组合物 |
CN102876764A (zh) * | 2012-10-05 | 2013-01-16 | 甘肃华羚生物技术研究中心 | 牦牛乳酪蛋白抑菌肽的制备方法 |
-
2014
- 2014-01-23 CN CN201410031586.8A patent/CN103750106B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103750106A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103750106B (zh) | 适用于流产后女性身体复原的牦牛蛋白多肽营养粉及其制备方法 | |
CN103749698B (zh) | 适用于产后妇女身体恢复的牦牛乳蛋白多肽营养粉及其制备方法 | |
CN104982937B (zh) | 一种促进骨质及骨膜修复的组合物及其制备方法 | |
CN103734581B (zh) | 适用于术后人群康复的牦牛乳蛋白多肽营养粉及其制备方法 | |
CN102845632B (zh) | 一种安全环保健康猪饲料添加剂 | |
CN115997920A (zh) | 一种用于创伤患者的全营养医学用途配方食品 | |
CN105614860A (zh) | 一种益生菌复配低聚肽降尿酸营养补充剂 | |
CN100506050C (zh) | 一种微米花果山金猴子糖消食益胃酸奶制备方法 | |
CN101803695B (zh) | 一种适用于少年儿童的补钙、补铁产品 | |
CN100350846C (zh) | 一种微米糖参马桃花鹿补肾消疲酸奶制备方法 | |
CN102845594B (zh) | 新型低胆固醇畜禽保健品 | |
CN104012848A (zh) | 一种虾蛄保健保鲜年糕及其制备方法 | |
CN100333652C (zh) | 一种微米糖参马桃花鹿补肾消疲奶粉制备方法 | |
CN107296098A (zh) | 一种促进骨骼增长婴幼儿营养包制剂 | |
CN105767997A (zh) | 一种蜂花粉及其制备方法 | |
CN109924367A (zh) | 一种改善蛋禽生理机能的饲料添加剂及其制备方法 | |
CN103070396B (zh) | 牦牛曲拉钙片保健组合物 | |
CN100569085C (zh) | 一种纳米鹿茸微米桃花鹿蚁壮阳消疲酸奶制备方法 | |
CN1331407C (zh) | 一种微米糖参马桃花鹿补肾消疲奶液制备方法 | |
CN100382710C (zh) | 一种微米花果山金猴子糖消食益胃奶粉制备方法 | |
CN100518523C (zh) | 一种微米金山仙人糖太子健脾消食酸奶制备方法 | |
CN102429147B (zh) | 一种用于患者术后调养的营养食品 | |
CN113331255A (zh) | 一种女士配方奶粉及其制备方法 | |
CN1806576B (zh) | 一种微米鹿茸红花仙子补肾消疲酸奶制备方法 | |
CN102366104A (zh) | 一种用于肿瘤患者的营养食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |